Next Article in Journal
The comparison of knee osteoarthritis treatment with single-dose bone marrow-derived mononuclear cells vs. hyaluronic acid injections
Previous Article in Journal
Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patients
Article Menu

Export Article

Medicina is published by MDPI from Volume 54 Issue 1 (2018). Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence. Articles are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Lithuanian Medical Association, Lithuanian University of Health Sciences, and Vilnius University.
Open AccessArticle
Medicina 2017, 53(3), 179-189; https://doi.org/10.1016/j.medici.2017.05.004 (registering DOI)

The influence of oxazaphosphorine agents on kidney function in rats

1
Department of Pathophysiology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland
2
Medical analytics graduate student, Jagiellonian University Medical College, Krakow, Poland
3
Department of Human Physiology and Pathophysiology, Faculty of Medicine, University of Rzeszów, Rzeszow, Poland
*
Author to whom correspondence should be addressed.
Received: 20 October 2016 / Revised: 10 April 2017 / Accepted: 2 May 2017 / Published: 2 July 2017
Full-Text   |   PDF [587 KB, uploaded 26 February 2018]   |  

Abstract

Background and objective: The application of cytostatic oxazaphosphorines such as cyclophosphamide (CP) and ifosfamide (IF) is associated with the risk of kidney damage that, depending on the type of drug, dose and route of administration, adopts a different clinical entity and severity. The aim of our study was to assess the influence of CP and IF on the kidney histology and function in rats intraperitoneally treated with four doses of either CP or IF. Materials and methods: A total of 30 rats were divided into three groups (10 in each group): group 1 (control), sham treated with saline solution, group 2 (treated with 75 mg/kg b.w. of CP), and group 3 (treated with 60 mg/kg b.w. of IF). After the treatment rats were sacrificed, blood was collected and nephrectomy and cystectomy were performed. Qualitative and quantitative parameters (including neutrophil gelatinase-associated lipocalin-1, NGAL-1) of kidney function were assayed in urine and plasma.
Results: CP-treated rats were characterized by a significant polyuria, decreased urine pH and by decreased daily urinary excretion of sodium, potassium, urea and uric acid accompanied by increased NGAL-1 excretion. A significant decrease of the plasma uric acid concentration was also observed. IF-treated animals were also characterized by decreased urine pH but with normal daily urinary excretion of assessed substances (except for reduced uric acid excretion).
Both CP and IF treated rats did not show any histopathological abnormalities in their kidneys.
Conclusions: CP caused more advanced kidney dysfunction and some indices suggested the development of prerenal acute kidney injury. In the CP-treated group some particularly marked urinary and plasma uric acid disturbances suggested compensation of increased oxidative stress as uric acid is considered to exert also antioxidant properties. View Full-Text
Keywords: Cyclophosphamide; Ifosfamide; Kidney; Nephrotoxicity; Rats Cyclophosphamide; Ifosfamide; Kidney; Nephrotoxicity; Rats
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives License (CC BY-NC-ND) (CC BY-NC-ND).

Share & Cite This Article

MDPI and ACS Style

Dobrek, Ł.; Skowron, B.; Baranowska, A.; Płoszaj, K.; Bądziul, D.; Thor, P. The influence of oxazaphosphorine agents on kidney function in rats. Medicina 2017, 53, 179-189.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Medicina EISSN 1010-660X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top